Article
Clinical management of hereditary breast cancer syndromes.
Journal of mammary gland biology and neoplasia - 1 Apr 2011
Clark Amy S, Domchek Susan M
Abstract excerpt
Over the past 15 years there has been substantial improvement in the understanding of hereditary breast cancer. Germline genetic testing for mutations in BRCA1, BRCA2, PTEN and TP53 allows for the identification of individuals at increased risk for breast, ovarian and other cancers. Advances in screening, prevention and treatment have led to improved clinical management which is best defined for BRCA1 and BRCA2...
Topics
- Breast Neoplasms
- Breast Self-Examination
- Early Detection of Cancer
- Early Diagnosis
- Female
- Genes, BRCA1
- Genes, BRCA2
- Genetic Predisposition to Disease
- Humans
- Magnetic Resonance Imaging
- Mammography
